Could the next pandemic be fungal and could we respond effectively? From plausible pathways to operational preparedness
The Lancet Microbe · 2026-11 · 101558
DOI: 10.1016/j.lanmic.2026.101558 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026-11. Verfasst von Victor Garcia-Bustos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain; University Institute of Animal Health and Food Safety (IUSA), Univ…. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Carlos III Health Institute.
Abstract (Originalsprache)
Fungal diseases cause substantial morbidity and mortality worldwide, yet they have been persistently neglected in pandemic preparedness plans, largely because no sustained human-to-human fungal pandemic has been documented to date. However, multidisciplinary evidence challenges the assumption that fungi are irrelevant to pandemic risk. Wildlife fungal pandemics show that mycoses can emerge on a global scale with catastrophic and irreversible consequences. Moreover, climate change is narrowing the mammalian thermal barrier against fungi, favouring heat-tolerant species, reshaping their global distribution, and thus facilitating zoonotic spillover. Rising human susceptibility-driven by ageing populations, immunomodulatory therapies, and increasingly complex health care-is intersecting with a substantial therapeutic gap, characterised by the absence of licensed vaccines, a limited range of antifungal agents, and increasing antimicrobial resistance. In this Personal View, we move beyond a synthesis of evidence to propose an operational framework for fungal pandemic preparedness, outlining plausible routes to pandemic-scale impact and the surveillance, diagnostic, therapeutic, One Health, and outbreak-response capacities needed to detect and contain emerging fungal threats before they become unmanageable.
Autor:innen und Institutionen
- Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain; University Institute of Animal Health and Food Safety (IUSA), University of Las Palmas de Gran Canaria, Arucas, Las Palmas, Spain. Elect…
- Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
- Institute of Zoology, Zoological Society of London, Regent's Park, London, UK.
Förderung
- National Institutes of Health
- Carlos III Health Institute
Zitieren
APA
Garcia-Bustos, V., Casadevall, A., & Cunningham, A. A. (2026). Could the next pandemic be fungal and could we respond effectively? From plausible pathways to operational preparedness. The Lancet Microbe, 101558. https://doi.org/10.1016/j.lanmic.2026.101558
Vancouver
Garcia-Bustos V, Casadevall A, Cunningham AA. Could the next pandemic be fungal and could we respond effectively? From plausible pathways to operational preparedness. The Lancet Microbe. 2026:101558. doi:10.1016/j.lanmic.2026.101558
BibTeX
@article{GarciaBustos2026,
author = {Garcia-Bustos, Victor and Casadevall, Arturo and Cunningham, Andrew A},
title = {Could the next pandemic be fungal and could we respond effectively? From plausible pathways to operational preparedness},
journal = {The Lancet Microbe},
year = {2026},
pages = {101558},
doi = {10.1016/j.lanmic.2026.101558}
}
EUVIMED